EGFR and neoplasm: In the present study, we analyzed ctDNA using the NOIR sequencing system in patients with non-small cell lung cancer (NSCLC) harboring EGFR T790M mutation to evaluate the therapeutic effect of osimertinib and behavior of tumor subclones during osimertinib treatment.